Sound Pharmaceuticals (SPI) is pleased to announce that the FDA has granted its investigational new drug, SPI-1005, ...

SEATTLE--(BUSINESS WIRE)--Sound Pharmaceuticals is pleased to announce that the Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory, for the treatment of Meniere’s Disease (STOPMD-3) ...

The U.S. Food and Drug Administration recently approved the first implantable device for people 18 and older with severe or profound sensorineural hearing loss of high-frequency sounds in both ears, ...

People with chronic obstructive pulmonary disease (COPD) are at increased risk of long-term hearing loss, researchers find. In a study on the association between chronic obstructive pulmonary disease ...

Inside the snug confines of the human ear lies a bony structure, curly and shaped like a seashell. This structure, called the cochlea, contains little hairy cells that vibrate when sounds pass through ...

At 47, Marlene Schultz thought she was much too young to keep saying “What?” when she couldn’t hear what people were telling her. The Pennsylvania accountant found it becoming difficult to make out ...

In a nationwide study of more than 1,500 teenagers aged 12 to 19, NYU School of Medicine researchers found that teenagers exposed to smoke, as determined by tests that showed cotinine (a metabolite of ...

SEATTLE--(BUSINESS WIRE)--Sound Pharmaceuticals is pleased to announce that the pivotal Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of ...